{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:46:57Z","timestamp":1784677617748,"version":"3.55.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.urology.2017.12.028","type":"journal-article","created":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T03:25:33Z","timestamp":1515036333000},"page":"60-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Safety and Feasibility of Intravesical Instillation of Botulinum Toxin-A in Hydrogel-based Slow-release Delivery System in Patients With Interstitial Cystitis-Bladder Pain Syndrome: A Pilot Study"],"prefix":"10.1016","volume":"114","author":[{"given":"Yishai H.","family":"Rappaport","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amnon","family":"Zisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Jeshurun-Gutshtat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tami","family":"Gerassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Hakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Vinshtok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kobi","family":"Stav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2017.12.028_bib0010","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.juro.2007.01.124","article-title":"Interstitial cystitis and painful bladder syndrome","volume":"177","author":"Payne","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.12.028_bib0015","series-title":"Diagnosis and Treatment Interstitial Cystitis\/Bladder Pain Syndrome. American Urological Association Guidelines","author":"Hanno","year":"2011"},{"key":"10.1016\/j.urology.2017.12.028_bib0020","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.urology.2007.04.038","article-title":"Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis","volume":"70","author":"Liu","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.urology.2017.12.028_bib0025","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.eururo.2005.12.002","article-title":"Botulinum A toxin intravesical injections in the treatment of painful bladder syndrome: a pilot study","volume":"49","author":"Giannantoni","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2017.12.028_bib0030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1479-666X(07)80084-9","article-title":"In-intravesical botulinum toxin type A in chronic interstitial cystitis: results of a pilot study","volume":"5","author":"Ramsay","year":"2007","journal-title":"Surgeon"},{"key":"10.1016\/j.urology.2017.12.028_bib0035","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.juro.2007.10.032","article-title":"Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup","volume":"179","author":"Giannantoni","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.12.028_bib0040","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.neuint.2007.11.006","article-title":"Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury","volume":"52","author":"Smith","year":"2008","journal-title":"Neurochem Int"},{"key":"10.1016\/j.urology.2017.12.028_bib0045","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.neuint.2005.04.021","article-title":"Enhanced ATP release from rat bladder urothelium during chronic bladder inflammation: effect of botulinum toxin A","volume":"47","author":"Smith","year":"2005","journal-title":"Neurochem Int"},{"issue":"suppl 1","key":"10.1016\/j.urology.2017.12.028_bib0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/PL00007816","article-title":"Pharmacology and immunology of botulinum toxin serotypes","volume":"248","author":"Aoki","year":"2001","journal-title":"J Neurol"},{"issue":"suppl 1","key":"10.1016\/j.urology.2017.12.028_bib0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1464-410X.2008.07822.x","article-title":"Mechanisms of action of intravesical botulinum treatment in refractory detrusor overactivity","volume":"102","author":"Drake","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2017.12.028_bib0060","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/nau.22760","article-title":"Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis\/bladder pain syndrome refractory to conventional treatment\u2014A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial","volume":"35","author":"Kuo","year":"2016","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2017.12.028_bib0065","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4065\/84.8.702","article-title":"Botulinum A toxin\/dimethyl sulfoxide bladder instillations for women with refractory idiopathic detrusor overactivity: a phase I\/II study","volume":"84","author":"Petrou","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.urology.2017.12.028_bib0070","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11255-010-9790-z","article-title":"Intravesical instillation of botulinum toxin-A: an in-vivo murine study and pilot clinical trial","volume":"43","author":"Khrut","year":"2011","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urology.2017.12.028_bib0075","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3109\/21681805.2015.1121406","article-title":"Intravesical instillation of onabotulinum toxin A embedded in inert hydrogel in the treatment of idiopathic overactive bladder: a double-blind randomized pilot study","volume":"50","author":"Khrut","year":"2016","journal-title":"Scand J Urol"},{"key":"10.1016\/j.urology.2017.12.028_bib0080","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2007.09.019","article-title":"Diagnosis criteria, classification, and nomenclature for painful bladder syndrome\/interstitial cystitis: an ESSIC proposal","volume":"53","author":"van de Merwe","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2017.12.028_bib0085","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ncpuro1124","article-title":"Drug Insight: biological effects of botulinum toxin A in the lower urinary tract","volume":"5","author":"Chancellor","year":"2008","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.urology.2017.12.028_bib0090","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0361-9230(03)00114-X","article-title":"Effect of stimulation intensity and Botulinum toxin isoform on rat bladder strip contractions","volume":"61","author":"Smith","year":"2003","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.urology.2017.12.028_bib0095","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/01.ju.0000137844.77524.97","article-title":"Intravesical botulinum toxin a administration produces analgesia against acetic acid induced bladder pain responses in rats","volume":"172","author":"Chuang","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.12.028_bib0100","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.urology.2004.10.057","article-title":"Effect of botulinum toxin on detrusor overactivity induced by intravesical adenosine triphosphate and capsaicin in a rat model","volume":"65","author":"Atiemo","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urology.2017.12.028_bib0110","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.ju.0000169481.42259.54","article-title":"Decreased sensory receptros P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity","volume":"174","author":"Apostolidis","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2017.12.028_bib0115","doi-asserted-by":"crossref","first-page":"13396","DOI":"10.1073\/pnas.231243698","article-title":"Vanilloid receptor expression suggests a sensory role for for urinary bladder epithelial cells","volume":"98","author":"Birder","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.urology.2017.12.028_bib0120","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.urology.2004.06.073","article-title":"Botulinum toxin A has antinociceptive effects in treating interstitial cystitis","volume":"64","author":"Smith","year":"2004","journal-title":"Urology"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429518300049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429518300049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T20:45:48Z","timestamp":1570567548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429518300049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":22,"alternative-id":["S0090429518300049"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2017.12.028","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732415440.793542584","asserted-by":"object"}]},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and Feasibility of Intravesical Instillation of Botulinum Toxin-A in Hydrogel-based Slow-release Delivery System in Patients With Interstitial Cystitis-Bladder Pain Syndrome: A Pilot Study","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2017.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}